Table 2 List of 84 genes analyzed in the vasculature by qRT-PCR for expression level

From: High dietary iron increases oxidative stress and radiosensitivity in the rat retina and vasculature after exposure to fractionated gamma radiation

 

CONTROL

RAD

IRON

IRON+RAD

Main Effect

     

RAD

IRON

IRON+RAD

Transmembrane

 Cd44

0.22±0.14

0.16±0.14

0.38±0.54

1.52±2.87

 

P=0.06

 

 Cdh2 (cadherin 2)

0.94±0.54

1.94±2.96

1.13±0.72

0.86±0.59

   

 Cdh3 (cadherin 3)

1.48±1.00

1.16±1.05

1.54±1.03

5.28±8.58

   

 Cdh4 (cadherin 4)

5.68±2.33

8.01±5.24

5.42±1.91

9.96±3.44

P=0.08

  

 Ncam1 (neural cell adhesion molecule 1)

17.75±6.58

11.31±6.54

18.29±13.02

17.99±19.39

   

 Ncam2 (neural cell adhesion molecule 2)

3.82±3.26

11.19±15.80

7.94±7.83

7.36±7.93

   

 Pecam1 (platelet/endothelial cell adhesion molecule 1)

64.83±46.27

48.01±17.11

57.65±31.41

61.31±35.57

   

 Sele (selectin E)

0.79±0.36

1.18±0.40

0.80±0.37

1.03±0.50

P=0.07

  

 Sell (selectin L)

23.58±30.03

68.30±76.86

15.38±26.57

3.16±2.49

   

 Selp (selectin P)

2.77±1.78

4.16±4.21

2.08±1.04

1.78±1.11

   

 Sgce (sarcoglycan, epsilon)

33.81±12.87

31.92±14.23

36.11±10.18

35.19±12.49

   

 Syt1 (synaptotagmin I)

6.43±8.60

3.76±1.60

9.87±9.61

11.55±18.56

   

Cell–cell adhesion

 Cdh1 (cadherin 1)

7.42±6.44

12.30±17.89

7.58±3.70

16.76±24.21

   

 Icam1 (intercellular adhesion molecule 1)

5.91±3.83

8.72±5.54

5.71±2.34

5.67±1.45

   

 Vcam1 (vascular cell adhesion molecule 1)

13.53±11.02

18.22±12.19

12.63±6.94

10.54±4.99

   

Cell–matrix adhesion

 Ctgf (connective tissue growth factor)

76.28±31.49

127.38±131.22

74.40±25.76

140.60±40.54

   

 Itga2 (integrin, alpha 2)

1.94±0.92

1.75±0.45

2.87±3.16

10.35±18.19

   

 Itga3 (integrin, alpha 3)

9.68±4.60

9.13±4.10

10.46±4.94

17.99±11.27

   

 Itga4 (integrin, alpha 4)

22.22±28.97

25.06±18.35

9.07±6.93

10.33±6.54

   

 Itga5 (integrin, alpha 5)

44.29±33.89

35.03±33.56

27.99±15.51

31.69±23.39

   

 Itgad (integrin, alpha D)

1.53±2.00

2.82±2.95

0.67±0.42

0.91±0.20

   

 Itgae (integrin, alpha E)

12.48±4.00

13.06±6.31

10.41±3.36

13.83±10.93

   

 Itgal (integrin, alpha L)

26.38±44.72

13.54±12.92

5.95±5.34

6.16±3.72

   

 Itgam (integrin, alpha M)

0.76±0.39

0.84±0.64

0.73±0.31

0.87±0.41

  

P=0.08

 Itgav (integrin, alpha V)

33.46±15.51

28.25±5.30

41.02±12.51

41.39±15.05

   

 Itgb1 (integrin, beta 1)

182.48±69.60

204.01±104.91

216.72±39.17

246.25±75.48

   

 Itgb2 (integrin, beta 2)

25.51±37.65

23.38±19.07

10.38±9.09

7.43±2.81

 

P=0.09

 

 Itgb3 (integrin, beta 3)

8.07±3.45

21.37±36.73

8.28±5.25

23.14±22.54

   

 Itgb4 (integrin, beta 4)

7.30±5.62

8.29±3.71

11.40±6.87

15.05±20.22

   

 Spp1 (secreted phosphoprotein 1)

12.66±8.27

6.31±2.93

11.96±12.26

2.73±1.76

P=0.07

P=0.05

 

Other adhesion molecules

 Catna1 (catenin, alpha 1)

60.83±31.70

32.35±14.23

57.39±25.88

62.54±41.35

   

 Ctnna2 (cadherin associated protein, alpha 2)

0.38±0.52

0.66±0.47

0.87±1.18

0.70±1.11

   

 Cntn1 (contactin 1)

1.47±2.23

0.75±0.44

1.02±0.74

1.08±1.02

   

 Ctnnb1 (cadherin associated protein, beta 1)

71.13±29.93

63.09±17.46

78.80±11.97

119.46±45.09

 

P=0.02

 

 Emilin1 (eastin microfibril interfacer 1)

4.63±1.56

11.11±17.14

4.51±2.28

7.38±4.06

   

 Fn1 (fibronectin 1)

44.46±21.46

36.06±15.89

43.93±18.43

29.98±17.90

   

 Postn (osteoblast specific factor)

112.89±34.70

159.26±90.42

155.67±83.42

190.23±158.34

   

 Tgfbi (transforming growth factor beta)

9.35±7.94

9.56±4.65

8.05±2.75

8.66±9.84

   

 Thbs1 (thrombospondin 1)

5.67±3.09

8.35±2.36

11.22±9.78

6.26±2.71

   

 Thbs2 (thrombospondin 2)

6.51±1.20

5.80±3.53

6.48±3.99

6.50±3.74

   

 Vtn (vitronectin)

9.94±6.06

6.69±4.68

11.10±5.35

9.96±6.79

   

Basement membrane

 Ecm1 (extracellular matrix protein 1)

15.23±9.63

3.82±2.23

8.26±4.32

9.21±6.82

   

 Entpd1 (ectonucleoside triphosphate diphosphohydrolase 1)

4.57±2.71

4.04±0.89

4.96±1.05

3.71±1.47

   

 Lama1 (laminin, alpha 1)

1.11±0.65

1.36±1.32

0.69±0.30

1.78±1.56

   

 Lama2 (laminin, alpha 2)

51.06±16.27

53.77±37.49

58.78±28.85

70.56±24.38

   

 Lama3 (laminin, alpha 3)

4.51±2.05

4.70±3.99

5.13±2.18

8.19±7.82

   

 Lamb2 (laminin, beta 2)

130.86±43.36

193.55±242.87

105.34±32.78

142.70±59.77

   

 Lamb3 (laminin, beta 3)

2.13±0.91

5.96±9.21

3.36±3.60

11.55±18.73

   

 Lamc1 (laminin, gamma 1)

96.26±46.52

74.61±26.54

121.24±44.02

96.79±45.21

   

 Sparc (secreted protein (osteonectin))

540.77±187.83

357.18±164.11

511.73±290.62

473.96±289.67

   

Collagens and ECM structure

 Col1a1 (collagen, type I)

110.77±74.48

51.29±29.09

89.93±45.03

50.24±37.26

P=0.04

  

 Col2a1 (collagen, type II)

0.33±0.41

0.35±0.34

0.22±0.14

0.55±0.37

   

 Col3a1 (collagen, type III)

522.01±176.67

362.30±162.60

508.44±157.25

356.68±136.37

P=0.01

  

 Col4a1 (collagen, type IV)

198.74±114.41

124.41±60.43

219.44±150.38

176.99±143.98

   

 Col4a2 (collagen, type IV)

41.49±21.29

29.76±17.65

44.60±34.00

33.27±21.15

   

 Col4a3 (collagen, type IV)

18.87±10.43

14.30±9.88

13.87±5.27

22.03±16.94

   

 Col5a1 (collagen, type V)

18.47±11.59

9.60±3.94

14.67±5.35

9.98±5.03

P=0.09

  

 Col6a1 (collagen, type VI)

14.03±9.57

5.43±2.63

10.23±7.81

7.34±4.63

   

 Col8a1 (collagen, type VIII)

0.28±0.15

0.40±0.48

0.16±0.09

0.42±0.27

   

 Hapln1 (hyaluronan and proteoglycan link protein 1)

0.34±0.23

0.95±1.65

0.30±0.27

0.72±0.86

   

ECM proteases

 Adamts1 (ADAM motif 1)

32.03±18.77

28.05±29.75

24.30±13.22

22.80±9.50

   

 Adamts2 (ADAM motif 2)

16.84±9.01

25.29±21.95

15.98±9.67

83.46±71.23

   

 Adamts5 (ADAM motif 5)

28.48±11.95

29.39±16.68

38.95±13.44

34.34±13.01

   

 Adamts8 (ADAM motif 8)

5.81±2.53

21.08±22.16

6.73±6.29

22.41±13.47

P=0.04

  

 Mmp1a (matrix metallopeptidase 1a)

0.16±0.11

0.74±1.31

0.09±0.04

0.36±0.14

  

P=0.06

 Mmp2 (matrix metallopeptidase 2)

37.38±19.73

26.66±6.11

35.14±7.02

28.07±9.29

   

 Mmp3 (matrix metallopeptidase 3)

0.16±0.19

0.20±0.27

0.13±0.09

0.34±0.23

 

P=0.07

P=0.08

 Mmp7 (matrix metallopeptidase 7)

0.67±0.36

1.99±2.86

1.06±0.97

1.41±1.04

   

 Mmp8 (matrix metallopeptidase 8)

0.76±0.61

0.53±0.23

0.36±0.21

0.58±0.25

  

P=0.02

 Mmp9 (matrix metallopeptidase 9)

7.19±5.17

5.78±2.63

4.18±3.03

10.26±8.73

   

 Mmp10 (matrix metallopeptidase 10)

17.69±7.81

20.99±15.52

10.42±5.52

98.65±106.91

  

P=0.05

 Mmp11 (matrix metallopeptidase 11)

61.56±32.37

23.82±12.73

20.40±17.17

56.75±43.71

  

P=0.04

 Mmp12 (matrix metallopeptidase 12)

3.53±5.57

4.36±6.16

0.89±1.00

0.54±0.39

   

 Mmp13 (matrix metallopeptidase 13)

0.49±0.24

0.65±0.47

0.35±0.15

0.85±0.54

   

 Mmp14 (matrix metallopeptidase 14)

10.03±6.96

5.03±5.11

9.50±6.63

7.83±7.42

   

 Mmp15 (matrix metallopeptidase 15)

18.41±7.96

11.20±7.66

16.45±7.83

30.42±23.80

  

P=0.07

 Mmp16 (matrix metallopeptidase 16)

0.96±0.56

0.32±0.17

0.54±0.36

0.26±0.30

   

ECM protease inhibitors

 Timp1 (TIMP metallopeptidase inhibitor 1)

39.52±4.18

82.88±91.21

40.40±15.26

44.86±22.59

   

 Timp2 (TIMP metallopeptidase inhibitor 2)

205.76±55.90

151.46±26.83

211.01±40.58

179.26±50.71

   

 Timp3 (TIMP metallopeptidase inhibitor 3)

80.40±51.11

37.11±18.82

79.17±56.02

62.78±38.61

   

Other ECM molecules

 Fbln1 (fibulin 1)

25.70±18.72

21.83±20.66

19.27±11.63

36.36±32.56

   

 Spock1 (sparc/osteonectin 1)

8.98±5.44

11.60±6.21

11.74±7.19

15.44±17.27

   

 Tnc (tenascin C)

6.24±6.89

3.05±1.44

4.52±3.37

2.95±1.39

   

 Vcan (versican)

20.72±9.59

32.96±40.49

19.53±8.65

19.74±10.78

   
  1. Abbreviations: ANOVA, analysis of variance; ECM, extracellular matrix; IRON, high-iron diet/no radiation; IRON+RAD, high-iron diet/radiation; qRT-PCR, quantitative reverse transcription PCR; RAD, adequate-iron diet/radiation.
  2. Expression level of 84 genes analyzed in the vasculature by qRT-PCR. The [(2−Δct)×1,000] values for all genes investigated in the vasculature are listed. P values are based on two-way ANOVA of the treatment effects calculated using Δct values.